Canaccord Genuity Reiterates a 'Buy' on MAP Pharmaceuticals (MAPP); Update From Global Growth Conference
Go back to Canaccord Genuity Reiterates a 'Buy' on MAP Pharmaceuticals (MAPP); Update From Global Growth Conference| Allergan Inc (NYSE: AGN) | Delayed: 193.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.02 | 52 Week High | $322.68 | |||
| Open | $15.33 | 52 Week Low | $186.34 | |||
| Day High | $193.02 | P/E | 45.96 | |||
| Day Low | $193.02 | EPS | $4.20 | |||
| Volume | 43,377 | |||||
| MAP Pharmaceuticals, Inc. (NYSE: MAPP) | Delayed: 28.15 +0.10 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.05 | 52 Week High | $25.03 | |||
| Open | $28.15 | 52 Week Low | $11.11 | |||
| Day High | $28.15 | P/E | N/A | |||
| Day Low | $28.15 | EPS | $-3.11 | |||
| Volume | 142 | |||||
